Register entry

Tonghua Dongbao Pharmaceutical Co., Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1sterilize1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Tonghua Dongbao Pharmaceutical Co., LtdDongbao New Village, Tonghua County, Tonghua, Jilin 134123, China (CHN)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize3005453288654457522
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Liraglutidepowder84934-001BULK INGREDIENT
Neighbours

Registered in the same town

1
Compare

Comparable companies in China

Enquiry

Common questions

Is Tonghua Dongbao Pharmaceutical Co., Ltd FDA approved?
Tonghua Dongbao Pharmaceutical Co., Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Tonghua Dongbao Pharmaceutical Co., Ltd's drugs manufactured?
The FDA register lists Tonghua. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.
What drugs does Tonghua Dongbao Pharmaceutical Co., Ltd make?
1 product is listed under Tonghua Dongbao Pharmaceutical Co., Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.